Orphalan announces US commercial launch of Cuvrior™ for the treatment of Wilson disease Cuvrior™ now available in the US for the treatment of adult patients with stable Wilson disease who are de-coppered and tolerant to penicillamine — Oral administration offers dosing flexibility and...